Chiho Ono

653 total citations
29 papers, 522 citations indexed

About

Chiho Ono is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Chiho Ono has authored 29 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Chiho Ono's work include Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and CAR-T cell therapy research (4 papers). Chiho Ono is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (7 papers) and CAR-T cell therapy research (4 papers). Chiho Ono collaborates with scholars based in Japan, United States and Germany. Chiho Ono's co-authors include Makoto Tanaka, Masayoshi Yamada, Ryo Atsumi, Kiyohiko Hatake, Michinori Ogura, Kensei Tobinai, Erik Vandendries, Yukio Kobayashi, Kiyoshi Ando and Shinji Yamazaki and has published in prestigious journals such as Blood, Applied and Environmental Microbiology and Annals of Oncology.

In The Last Decade

Chiho Ono

29 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiho Ono Japan 14 199 169 95 93 79 29 522
Mukul Minocha United States 13 256 1.3× 151 0.9× 32 0.3× 56 0.6× 45 0.6× 32 612
Łukasz Sędek Poland 16 113 0.6× 306 1.8× 77 0.8× 52 0.6× 181 2.3× 59 771
Pradeep S. Chauhan United States 18 159 0.8× 356 2.1× 48 0.5× 35 0.4× 116 1.5× 70 836
Parul Gupta India 11 185 0.9× 260 1.5× 45 0.5× 41 0.4× 40 0.5× 41 582
T. L. Loo United States 10 175 0.9× 206 1.2× 72 0.8× 57 0.6× 23 0.3× 27 522
Yue-Li Sun China 10 230 1.2× 248 1.5× 39 0.4× 32 0.3× 13 0.2× 23 535
Du‐Shieng Chien United States 15 148 0.7× 314 1.9× 55 0.6× 22 0.2× 24 0.3× 22 783
Ross O. Meyers United States 16 150 0.8× 281 1.7× 24 0.3× 36 0.4× 103 1.3× 27 974
Naveed Shaik United States 8 408 2.1× 159 0.9× 16 0.2× 78 0.8× 39 0.5× 8 655

Countries citing papers authored by Chiho Ono

Since Specialization
Citations

This map shows the geographic impact of Chiho Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiho Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiho Ono more than expected).

Fields of papers citing papers by Chiho Ono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiho Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiho Ono. The network helps show where Chiho Ono may publish in the future.

Co-authorship network of co-authors of Chiho Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Chiho Ono. A scholar is included among the top collaborators of Chiho Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiho Ono. Chiho Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roth, Joshua A., et al.. (2024). A descriptive analysis of real-world oncology biosimilar use in Japan. Future Oncology. 20(25). 1837–1850. 1 indexed citations
2.
Ono, Takaaki, Masayuki Hino, Itaru Matsumura, et al.. (2022). Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study. International Journal of Hematology. 116(6). 871–882. 7 indexed citations
3.
Takahashi, Naoto, Jörge E. Cortes, Emiko Sakaida, et al.. (2022). Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis. International Journal of Hematology. 115(6). 838–851. 4 indexed citations
4.
Chuah, Charles, Liang Piu Koh, Tontanai Numbenjapon, et al.. (2021). Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trial. International Journal of Hematology. 114(1). 65–78. 7 indexed citations
5.
Fujishima, Naohito, Toshiki Uchida, Yasushi Onishi, et al.. (2019). Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia. International Journal of Hematology. 110(6). 709–722. 8 indexed citations
6.
Takahashi, Naoto, Chiaki Nakaseko, Yukio Kobayashi, et al.. (2017). Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment. International Journal of Hematology. 106(3). 398–410. 7 indexed citations
7.
Yoshino, Takayuki, Kohei Shitara, Hiroya Taniguchi, et al.. (2015). PF-05212384 + irinotecan Phase II study in metastatic colorectal cancer (mCRC): B2151005 Japanese lead-in-cohort (J-LIC). Annals of Oncology. 26. vii72–vii72. 1 indexed citations
8.
Ono, Chiho, et al.. (2013). Clinical Impact of Genetic Variants of Drug Transporters in Different Ethnic Groups within and Across Regions. Pharmacogenomics. 14(14). 1745–1764. 16 indexed citations
9.
Lai, Yurong, Manthena V. S. Varma, Bo Feng, et al.. (2012). Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development. Expert Opinion on Drug Metabolism & Toxicology. 8(6). 723–743. 45 indexed citations
10.
Ogura, Michinori, Kiyohiko Hatake, Kiyoshi Ando, et al.. (2012). Phase I study of anti‐CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B‐cell non‐Hodgkin lymphoma. Cancer Science. 103(5). 933–938. 55 indexed citations
11.
Ogura, Michinori, Kensei Tobinai, Kiyohiko Hatake, et al.. (2010). Phase I study of inotuzumab ozogamicin (CMC‐544) in Japanese patients with follicular lymphoma pretreated with rituximab‐based therapy. Cancer Science. 101(8). 1840–1845. 46 indexed citations
12.
Shimizu, Shinji, Ryo Atsumi, Masaru Iwasaki, et al.. (2009). Metabolism-dependent hepatotoxicity of amodiaquine in glutathione-depleted mice. Archives of Toxicology. 83(7). 701–707. 57 indexed citations
13.
Takeda, Yasuyuki, Kouichi Uoto, Michio Iwahana, et al.. (2004). New highly active taxoids from 9β-dihydrobaccatin-9,10-acetals. Part 5. Bioorganic & Medicinal Chemistry Letters. 14(12). 3209–3215. 2 indexed citations
14.
15.
Ono, Chiho, et al.. (2004). Absorption, Distribution, and Excretion of DJ-927, a Novel Orally Effective Taxane, in Mice, Dogs, and Monkeys. Biological and Pharmaceutical Bulletin. 27(3). 345–351. 20 indexed citations
16.
Takeda, Yasuyuki, Kouichi Uoto, Jun Chiba, et al.. (2003). New highly active taxoids from 9β-Dihydrobaccatin-9,10-acetals. Part 4. Bioorganic & Medicinal Chemistry. 11(20). 4431–4447. 14 indexed citations
17.
Ono, Chiho & Makoto Tanaka. (2003). Binding characteristics of fluoroquinolones to synthetic levodopa melanin. Journal of Pharmacy and Pharmacology. 55(8). 1127–1133. 34 indexed citations
18.
Shiba, Yoichiro, Chiho Ono, Fumio Fukui, et al.. (2001). High-Level Secretory Production of Phospholipase A1by Saccharomyces cerevisiae and Aspergillus oryzae. Bioscience Biotechnology and Biochemistry. 65(1). 94–101. 21 indexed citations
19.
Shiba, Yoichiro, Chiho Ono, Fumio Fukui, & Hiroji Yoshikawa. (2000). Effect of ethanol on the production of carboxypeptidase Y using the GAL10 promoter in a Saccharomyces cerevisiae gal80 mutant. Journal of Bioscience and Bioengineering. 89(5). 426–430. 3 indexed citations
20.
Shiba, Yoichiro, Chiho Ono, Kimihisa Ichikawa, Nobufusa Serizawa, & Hiroji Yoshikawa. (1999). Isolation and Characterization of the Gene Conferring Thiamine-inducible Expression fromSaccharomyces cerevisiae. Bioscience Biotechnology and Biochemistry. 63(8). 1414–1419. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mukul Minocha Breakdown of academic impact, for papers by Łukasz Sędek Breakdown of academic impact, for papers by Pradeep S. Chauhan Breakdown of academic impact, for papers by Parul Gupta Breakdown of academic impact, for papers by T. L. Loo Breakdown of academic impact, for papers by Yue-Li Sun Breakdown of academic impact, for papers by Du‐Shieng Chien Breakdown of academic impact, for papers by Ross O. Meyers Breakdown of academic impact, for papers by Naveed Shaik
Rankless by CCL
2026